Stockreport

Consider Buying Potential Takeover Target Altimmune [Seeking Alpha]

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors
PDF Follow Play 8min Summary Altimmune, Inc.'s weight loss drug, pemvidutide, shows significant superiority in lean mass retention and liver fat reduction, making i [Read more]